Workflow
Restoris™ piezoelectric dental gel
icon
Search documents
Phibro Animal Health Corporation Declares Quarterly Dividend
Businesswire· 2025-11-04 21:10
Core Viewpoint - Phibro Animal Health Corporation has declared a quarterly cash dividend of $0.12 per share for its Class A and Class B common stock, payable on December 17, 2025, to stockholders of record as of November 26, 2025 [1] Company Overview - Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company, aiming to be a trusted partner for livestock producers, farmers, veterinarians, and consumers by providing solutions to enhance animal health [2] Recent Developments - The company announced the national launch of Restoris™ piezoelectric dental gel for dogs, designed to support long-term oral health in dogs with periodontal disease, developed in collaboration with a leading U.S. dental school [3][5] - Phibro has entered into a licensing agreement with Lighthouse Pharmaceuticals, Inc. for a novel therapeutic asset targeting periodontal health in companion animals, granting Phibro exclusive rights to develop, manufacture, and commercialize the proprietary compound [7]
Phibro Animal Health Corporation Announces National Launch of Restoris™ Piezoelectric Dental Gel for Dogs
Businesswire· 2025-10-30 17:00
Core Insights - Phibro Animal Health Corporation has launched Restoris™ piezoelectric dental gel, aimed at improving oral health in dogs suffering from periodontal disease [1] - The product was developed in collaboration with a prominent U.S. dental school and is licensed to Phibro, indicating a strong foundation in veterinary dental care innovation [1] - Restoris™ employs a dual mechanism of action to restore oral health, marking a significant advancement in the veterinary dental care market [1] Company Overview - Phibro Animal Health Corporation is positioning itself as a leader in veterinary dental care with the introduction of Restoris™, highlighting its commitment to enhancing animal health [1] - The collaboration with a leading dental school underscores the company's focus on research and development in the veterinary sector [1] Industry Impact - The launch of Restoris™ is expected to address a critical need in the veterinary market for effective treatments for periodontal disease in dogs, potentially expanding the company's market share [1] - This innovation may set a new standard in veterinary dental care, influencing competitors and driving further advancements in the industry [1]